Form 8-K - Current report:
SEC Accession No. 0001437749-22-020547
Filing Date
2022-08-15
Accepted
2022-08-15 16:35:59
Documents
15
Period of Report
2022-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20220815_8k.htm   iXBRL 8-K 31281
2 EXHIBIT 99.1 ex_412974.htm EX-99.1 166681
7 ex_412974img001.jpg GRAPHIC 5292
  Complete submission text file 0001437749-22-020547.txt   353900

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbla-20220815.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20220815_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20220815_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20220815_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT pbla20220815_8k_htm.xml XML 2553
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 221166159
SIC: 2834 Pharmaceutical Preparations